Matches in Wikidata for { <http://www.wikidata.org/entity/Q91246450> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q91246450 description "article scientifique publié en 2019" @default.
- Q91246450 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91246450 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91246450 description "scientific article published on 09 November 2019" @default.
- Q91246450 description "wetenschappelijk artikel" @default.
- Q91246450 description "наукова стаття, опублікована 9 листопада 2019" @default.
- Q91246450 name "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 name "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 type Item @default.
- Q91246450 label "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 label "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 prefLabel "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 prefLabel "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 P1433 Q91246450-568DF565-2737-48C7-BE77-299B737B0826 @default.
- Q91246450 P1476 Q91246450-33B1A6AF-66FE-4062-8CCC-CB4795B30784 @default.
- Q91246450 P2093 Q91246450-1DBE1FD4-6816-43B7-A313-1052B2669F1B @default.
- Q91246450 P2093 Q91246450-2C2028CE-7B1F-42B7-B0E1-FF4B67AB2662 @default.
- Q91246450 P2093 Q91246450-926A5D17-3A9B-4988-81FE-E16BC36A4E8E @default.
- Q91246450 P2093 Q91246450-95C981DE-CCFC-419C-B9B7-FE25290D4C07 @default.
- Q91246450 P2093 Q91246450-9ADDCA84-95EF-45F6-BA00-1C76CC0776D0 @default.
- Q91246450 P2860 Q91246450-F5927D4F-039C-4269-B16B-CDC21E312C19 @default.
- Q91246450 P304 Q91246450-0AF3B1F2-94A8-4B3A-9237-71955C4D6B43 @default.
- Q91246450 P31 Q91246450-EE1295FE-C0CF-4FC9-BF3F-3BEF4E593C07 @default.
- Q91246450 P356 Q91246450-50147806-6771-4A47-B098-DE041A09BAAF @default.
- Q91246450 P478 Q91246450-EBBFF57D-2CDB-4B39-AFCA-1AEA6D091980 @default.
- Q91246450 P50 Q91246450-290212F5-A969-4880-9047-6B8DEE68ABEC @default.
- Q91246450 P50 Q91246450-4C1903CE-8F65-43BA-AD18-722EEED3CC86 @default.
- Q91246450 P50 Q91246450-5B897905-060F-4F03-8694-4AB7C1399866 @default.
- Q91246450 P50 Q91246450-746A3F33-7316-4B8B-A681-C8138A91A5C0 @default.
- Q91246450 P50 Q91246450-7534120A-05E4-41C9-9776-4970677864D5 @default.
- Q91246450 P50 Q91246450-86B67A3C-1E09-4017-9CA4-DF97F4F7B2DD @default.
- Q91246450 P50 Q91246450-9195CAAA-5B0D-41AC-8950-C82F711CB303 @default.
- Q91246450 P577 Q91246450-1CDEE824-46CA-4641-8C34-D3830C21E78C @default.
- Q91246450 P698 Q91246450-4B78F206-1171-4F93-A1A5-3767EAC923A5 @default.
- Q91246450 P356 J.IJPHARM.2019.118826 @default.
- Q91246450 P698 31715352 @default.
- Q91246450 P1433 Q6051539 @default.
- Q91246450 P1476 "Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications" @default.
- Q91246450 P2093 "Felisa Cilurzo" @default.
- Q91246450 P2093 "Luisa Di Marzio" @default.
- Q91246450 P2093 "Maria Chiara Cristiano" @default.
- Q91246450 P2093 "Massimo Fresta" @default.
- Q91246450 P2093 "Sini Miettinen" @default.
- Q91246450 P2860 Q91175713 @default.
- Q91246450 P304 "118826" @default.
- Q91246450 P31 Q13442814 @default.
- Q91246450 P356 "10.1016/J.IJPHARM.2019.118826" @default.
- Q91246450 P478 "573" @default.
- Q91246450 P50 Q28468917 @default.
- Q91246450 P50 Q43143343 @default.
- Q91246450 P50 Q59177130 @default.
- Q91246450 P50 Q59702803 @default.
- Q91246450 P50 Q87974729 @default.
- Q91246450 P50 Q88944164 @default.
- Q91246450 P50 Q90672479 @default.
- Q91246450 P577 "2019-11-09T00:00:00Z" @default.
- Q91246450 P698 "31715352" @default.